
    
      PROTOCOL OUTLINE: All patients receive a gonadotropin-releasing hormone (GnRH) analogue.
      Treatment begins on days 1 to 3 of a menstrual cycle.

      Low-dose estrogen begins at approximately 3 months. All patients must have a daily calcium
      intake of at least 1 gram; supplements are allowed.

      Patients are followed for at least 1 year.
    
  